Is the Nufarm share price in the buy zone?

The Nufarm Limited (ASX: NUF) share price has had a tumultuous start to 2019. Is it a buy?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nufarm Limited (ASX: NUF) share price has had a tumultuous start to 2019. After a slight rally, the company's share price was slashed more than 20% following the release of its half-year results.

However, the relentless selling may be overdone, presenting a decent buying opportunity.

Disappointing results

Seed and crop protection company Nufarm reported its half-year results for the period ending January 2019 last week and the market was not impressed. Nearly $500 million was slashed from the value of the company as Nufarm's share price plummeted almost 23%.

Highlights of the report included an 8% increase in revenue to $1.58 billion, however the company recorded a $13.6 million loss for the first half. Underlying EBITDA was down 2% to $121 million and the interim dividend suspended. Net debt rose from $981 million to $1.58 billion, raising concerns that Nufarm would require a round of capital raising.

The effects of drought

The lack of winter rain was cited by Nufarm in mid-2018, as the company downgraded its earnings guidance twice. The extremely dry conditions affected crop and livestock production, reducing the demand for crop protection and causing an oversupply and reduction in profit margins. As a result, Nufarm announced that production at two formulation plants in Melbourne would be cut back.

Omega 3 Potential

To combat the cyclical nature of crop production and protection, Nufarm is investing heavily in R&D. In partnership with the CSIRO, Nufarm's subsidiary Nuseed is developing and commercialising omega-3 derived from canola. The omega-3 produced from canola has been shown to achieve the same levels of docosahexaenoic acid (DHA) as regular fish oil.

Omega-3 and DHA are important components of many products popular in China, in particular milk and infant formula. The rationale is that as pressure on global fish stocks increases, demand for alternative sources for omega-3 and DHA will increase.

Foolish takeaway

In my opinion, the sell-off in the Nufarm share price could be interpreted as an overreaction. The company has a quality portfolio of agricultural products and if the share price continues to drop, Nufarm could become a takeover target. The potential in omega-3 is also very intriguing, however, I would wait until FDA accreditation is received. Goldman Sachs sees great potential in Nufarm and has issued a buy rating on the company with a price target of $6.00.

Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »